RE:RE:RE:RE:RE:RE:RE:Selling pressureDon't stress, biopharma plays are boring, until there's big news then bam they get exciting. Judging where these guys are in their drug pipeline, it's going to be a while before we see a massive push on it's market cap. But let's say their furthest along drug gets approval soon, watch the market cap soar to reflect that and be comparable to peers. Reminds me of my flying days, "long periods of sheer boredom, interspersed with moments of sheer excitement" (or sheer terror used in the flying saying)
This stock is a classic case of "reward the patient", so be patient my friend
RonalDent wrote: 30$... wow seems really optimistic. I'm starting to lose faith in this stock quick. Glad I only sunk 2k into it.. GLTA